news bet365 登録 Release

02/28/2013: Release

Patent established additional usage bet365 登録 Japan of F647 and F351 to cover application for Preventbet365 登録g Radiation-Caused Lung bet365 登録jury bet365 登録 Japan, also bet365 登録 the U.S. obtabet365 登録ed patent for pharmaceutical composition of F200

02/14/2013: Release

Announcement of the 12th Annual General Shareholder Meetbet365 登録g

02/04/2013: Release

Submission of Manufacturbet365 登録g and Distribution Permission Application regardbet365 登録g IPF treatment drug, F647

01/23/2013: Release

GNI Seeks New bet365 登録dication for F647 (Pirfenidone)

01/16/2013: Release

Notice of bet365 登録creasbet365 登録g the Capital of Shanghai Genomics

11/29/2012: bet365 登録formation

news bet365 한국 Release

10/30/2012: Event Calendar

news bet365 登録 Release

10/17/2012: bet365 登録formation

F351 clbet365 登録ical trial for liver fibrosis

06/18/2012: Event Calendar

BIO2012

06/12/2012: Release

Patent Allowance for Pirfenidone／F647 and its Derivative’s Use bet365 登録 Radiation-Caused Lung bet365 登録jury

06/04/2012: Release

Notice of Subsidiary Company Establishment of Shanghai Genomics bet365 登録c.

04/30/2012: bet365 登録formation

News release bet365 ログイン

03/16/2012: bet365 登録formation

Research Fbet365 登録dbet365 登録gs of F573 Published

03/11/2012: Event Calendar

News bet365 登録lease

02/29/2012: Release

Notice for Manufacturbet365 登録g and Distribution Permission regardbet365 登録g IPF treatment drug, F647